Key stats
About PHARMACEUTICAL INDUSTRY
Home page
Inception date
Mar 28, 2013
Structure
Open-Ended Fund
Replication method
Physical
Dividend treatment
Distributes
Primary advisor
China Asset Management Co., Ltd.
ISIN
CNE0999004D1
Closely track the underlying index, Tightly track the target and minimize the deviation, in order to obtain a return similar to the underlying index return.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks99.49%
Health Technology90.11%
Retail Trade2.76%
Health Services2.15%
Process Industries1.71%
Distribution Services1.29%
Transportation0.95%
Commercial Services0.51%
Electronic Technology0.01%
Bonds, Cash & Other0.51%
Cash0.46%
Miscellaneous0.05%
Stock breakdown by region
Asia98.16%
Europe1.84%
North America0.00%
Latin America0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
510660 invests in stocks. The fund's major sectors are Health Technology, with 90.11% stocks, and Retail Trade, with 2.76% of the basket. The assets are mostly located in the Asia region.
510660 top holdings are Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A and WuXi AppTec Co., Ltd. Class A, occupying 14.62% and 13.72% of the portfolio correspondingly.
510660 assets under management is 85.68 M CNY. It's risen 1.28% over the last month.
510660 fund flows account for −18.38 M CNY (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, 510660 doesn't pay dividends to its holders.
510660 shares are issued by CITIC Securities Co., Ltd. under the brand ChinaAMC. The ETF was launched on Mar 28, 2013, and its management style is Passive.
510660 expense ratio is 0.60% meaning you'd have to pay 0.60% of your investment to help manage the fund.
510660 follows the SSE Medical and Health Industry Index - CNY - Benchmark TR Gross. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
510660 invests in stocks.
510660 price has risen by 5.47% over the last month, and its yearly performance shows a 13.38% increase. See more dynamics on 510660 price chart.
NAV returns, another gauge of an ETF dynamics, have risen by 5.64% over the last month, showed a 8.91% increase in three-month performance and has increased by 14.35% in a year.
NAV returns, another gauge of an ETF dynamics, have risen by 5.64% over the last month, showed a 8.91% increase in three-month performance and has increased by 14.35% in a year.
510660 trades at a premium (0.19%) meaning the ETF is trading at a higher price than the calculated NAV.